Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
is looking for consultants with experience and expertise in the Asian regenerative medicine markets.
Nanotech + cell therapy for diabetics http://www.smartplanet.com/people...
very much enjoyed the 1st Cell Therapy Industry Summit last week in Carlsbad, CA. Thanks LifeTechnologies for a great conference.
Dendreon (Nasdaq: DNDN) has submitted its BLA for cell therapy for PROVENGE® for prostate cancer. http://investor.dendreon.com/Release...
Cell therapy company Organogenesis to speak at opening night of this week's TedMed. http://www.bio-medicine.org/biology...
I suspect this is the first time the FDA has had two cell therapy BLAs under consideration. Dendreon & Fibrocell.
The LinkedIn Cell Therapy Industry Group passed the 500 member mark this week.
Good ref: The Challenge of Orthobiologics: Navigating Coverage and Reimbursement in a Complex Marketplace - http://www.mcra.com/whitepa...
i want an invite to Googe Wave (just thought I'd put that out there...)
The true status of the cell therapy industry... - http://celltherapyblog.blogspot.com/2009...
The true status of the cell therapy industry...
@fredcobio Are we going to see you at the stem cell summit in Baltimore next week or do I have to book a private beer session?
@JonRowley Looking forward to seeing you in Baltimore next week and checking out what you'll show me of the shiny Lonza plant!
Who's going to the Wold Stem Cell Summit in Bal'more in a week and a bit?
Trying to get used to working of multiple monitors. It's cool but harder than I thought.
Seriously, what are u listening to? I'm listening to OnlineRadioStations.com 6000+ stations in every genre from around the world. Free.
@cell_nnm I think Karolinska has a fairly late-stage MSC trial in GvHD but academic trials are more your domain than mine!
Ahhh the love. missed you all too! xoxo Frances, glad to report that all other spheres were spinning fine whilst my Twittersphere derailed
I'm back. Anybody miss me? August had too little office chair time to fit Twitter in.
Usual positive spin from Osiris. If GvHD had worked, investors would've forgot bad news in Crohn's + COPD but this one's going to hurt
Weird day for cell therapy. Osiris stock plummeting. Opexa Therapuetics stock skyrocketing.
Opexa Therapeutics announced positive 52-week follow-up data in patients treated with Tovaxin cell therapy for MS - http://finance.yahoo.com/news...
Congrats to @jennhaynen on making the move to biotech! Genentech is lucky to have you.
No one said cell therapy was easy. Both Osiris phase III trials of Prcochymal in GvHD fail to meet endpoints http://bit.ly/pfHo0
Lee is as excited as a boy at Xmas with his new Sony VAIO he just unwrapped. OMG its beautiful.
We'll have to work on that Mary... @Comprendia: would be cool if we could all work together! @whitecoatstrat http://www.marketwire.com/press-r...
Congrats to @whitecoatstrat + @Comprendia on new partnership re: integrated social media, video & PR for biotech fims http://www.marketwire.com/press-r...
I'm back to the Twittersphere after a 1 week "holiday" with the niece and nephew. Time to rest up in the office chair!
With its deal with Opexa late last week, that gives Novartis 2 cell therapy plays
J&J, Pfizer, Roche, Abbott, Celgene, Novartis, Axcan, Novo Nordisk + Teva have all made entrées into cell therapy. Sanofi & others r looking
RT @StemCellNetwork: Canadian stem cell researchers Eaves and Dick to receive hematology awards http://scnblog.typepad.com/scnblog...
Other ways to read this feed:Feed readerFacebook